Project Grant R01CA290675
Award Date
9/20/24
Completion Date
8/31/29
Dollars Obligated
$1.2M
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
Minnesota, USA
Similar Awards
This Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) will evaluate population-based strategies for improving smoking cessation among rural residents. The key focus is to determine the efficacy of providing a free nicotine replacement therapy (NRT) starter kit, along with digital NRT education, to rural people who smoke. The $694,771 award to the Regents of the University of Minnesota will...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,965,600.00 to the University of Colorado-Denver to conduct research aimed at improving smoking cessation efficacy among American Indian communities. The key objectives of this 21-month project are to: 1) identify genetic and epigenetic influences on nicotine metabolism in American Indian smokers, 2) develop genetic risk scores to examine...
This Project Grant award from the National Cancer Institute (NCI), under the federal Cancer Cause and Prevention Research program (CFDA 93.393), provides $515,632 to the Regents of the University of Minnesota to conduct research aimed at ensuring the U.S. is fully prepared to maximize smoking cessation during and following the implementation of proposed cigarette product standards by the U.S. Food and Drug Administration (FDA). The key objectives of this 3-year project are to: 1) Estimate, for...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $757,913 to the Fred Hutchinson Cancer Center in Seattle, WA to conduct a randomized controlled trial assessing the efficacy and cost-effectiveness of providing Hispanic adults who smoke with a smoking cessation smartphone app (iCanQuit) alone versus the app combined with free nicotine replacement therapy. The goal is to determine whether the addition of free nicotine...
The federal Project Grant award R01CA298165 was provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program. The $625,201 award will fund a 5-year randomized factorial trial to evaluate the combined impact of varenicline, nicotine lozenges, and a smartphone-based medication adherence intervention on smoking cessation outcomes among 496 adult daily smokers. The study aims to improve smoking cessation treatment and reduce cancer risk. A...
This Project Grant award of $447,000 from the National Institute on Minority Health and Health Disparities (CFDA 93.307 Minority Health and Health Disparities Research) aims to assess the effectiveness of culturally targeted anti-smoking messages for high-risk Asian American (AA) ethnic subgroups, including Korean, Vietnamese, and Filipino Americans. The research will evaluate deep (reflecting cultural values) and surface structure (featuring Asian models) targeting strategies through in-depth...
This Project Grant award of $801,832 from the National Institutes of Health (NIH) Trans-NIH Research Support program (CFDA 93.310) supports a multilevel integrated intervention to improve low-dose computed tomography (LDCT) lung cancer screening and smoking cessation among African Americans. The primary objectives are to investigate smokers' and providers' attitudes, knowledge, and experiences with the expanded 2021 USPSTF lung cancer screening recommendations, compare the effectiveness of the...
This Project Grant award from the National Cancer Institute (NCI), under the federal Cancer Cause and Prevention Research program (CFDA 93.393), will support a hybrid effectiveness-implementation trial to evaluate a novel harm reduction approach for oncology outpatients who smoke but refuse traditional tobacco treatment. The $619,175 award, effective December 1, 2024, will be used by the Medical University of South Carolina to directly compare rates of switching from cigarettes to e-cigarettes...
This Project Grant award, with Federal Grant Award ID R01CA296150, was provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) federal grant program. The award of $667,828 supports a research project to adapt and implement the Ask-Advise-Connect (AAC) tobacco cessation model in community-based food pantry settings, in order to enhance the reach and effectiveness of tobacco quitline services for socioeconomically disadvantaged populations....
The University of Oklahoma Health Sciences Center was awarded a $794,090 Project Grant from the National Cancer Institute (NCI) under the federal Cancer Cause and Prevention Research program (CFDA 93.393). The grant, awarded on August 1, 2024, aims to develop and pilot test culturally sensitive digital outreach interventions to increase rates of diagnostic colonoscopy among Native American populations in Oklahoma. The key products and services to be delivered under this grant include: 1)...